Vendor, Fairfax, VA
Immudex Usa, LLC
UEI TBNLHW1MFEJ1, CAGE 63GQ8
1 award and $24,964 obligated between July 22, 2026 and July 22, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | $24,964 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N98026P01096Purchase Order, July 22, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health OlaoNational Institutes of Health | NCI - Custom MHC Class II HLA-DP Xynapse and Dextramer Reagents for Liver Cancer Neoantigen ValidationNAICS 325413, PSC 6505 | $24,964 |
- Places of performance
- Virginia
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards